Opioid antagonist naloxone should be available from community pharmacies to help prevent fentanyl overdose deaths, new guidance from Public Health England (PHE) says.

The guidance, developed by PHE in conjunction with the Local Government Association (LGA), is aimed at helping local commissioners address the problem of illicit strong opioids such as fentanyl in some communities.

The guidance includes the recommendation that naloxone, the emergency antidote for overdoses caused by opiates and opioids, should be available from a greater range of community resources such as community pharmacies and homeless services.

Local areas are advised to investigate where the problem lies within their community and how severe the problem is, for example by using the local drug information system (LDIS) professional information network (PIN) if there is one in the area.

PHE recommends that frontline services such as pharmacies and A&E departments incorporate safer drug use messages such as ‘Drug supplies change, best test first’, ‘Look out for your mates’ and ‘Naloxone – get it, carry it, use it’ in interactions with opioid users.

 

Originally Published by Pharmacy Magazine

Recommended

NHS moves to tackle medication errors

To help the NHS monitor medication errors, a series of indicators are being introduced to show whether a prescription ma...

Measles warning

The increase in measles circulation is mainly associated with travel to and from Europe where there are large ongoing me...

Popular

Why apply for a split pre-registration training programme

Applications for pre-registration training 2019-2020 are now open, with a staggering amount of places to choose from, To...

Bladder weakness programme: Understanding pharmacy’s role

This module is designed to help you make a difference to customers with bladder weakness and will equip you with the kno...

The 13 steps to GDPR – put the regulations into practice

All pharmacies should complete a Data Protection Impact Assessment (DPIA), suggests PSNC


By using this website, you accept British Pharmaceutical Students' Association Terms of Use, Privacy Policy and Cookie Policy. Click accept to hide box. By continuing browsing you have confirmed your acceptance.